A man arrives on a Tuesday afternoon carrying a grocery bag of pill bottles. Two prescriptions are current. One was written by a psychiatrist he stopped seeing three years ago. One has his wife’s name on the label. He has been taking an antidepressant most mornings, occasionally two when the day already feels bad, and drinking on top of it since spring. His first question, before he takes off his jacket, is whether we are going to take everything away.

Some version of that conversation happens most weeks. Psychiatric medication is one of the most misunderstood parts of residential addiction treatment, and families usually ask about it last. This article explains how medication management actually works inside a residential dual diagnosis program, what gets reviewed, what tends to change, and what a reasonable plan looks like at discharge.

Why the bag of bottles matters more than it looks

Most people who arrive at a residential program are not medication-naive. They have been prescribed something at some point — for depression, anxiety, sleep, attention, pain — often by different prescribers who never spoke to one another. Refills lapse. Doses drift. A medication started for panic attacks years ago is still being taken because nobody revisited it.

What complicates this in addiction treatment is that alcohol and other drugs interact with nearly all of it. Sedatives stack. Alcohol blunts some antidepressants and amplifies the sedation of others. Prescribed stimulants can be taken in escalating amounts once tolerance builds. None of that is visible from a medication list alone, which is why the first task is reconstruction rather than prescribing.

What happens in the first seventy-two hours

Medication decisions early in treatment are deliberately conservative. Within the first day or two, a psychiatric provider reviews the full list, verifies what can be verified with outside prescribers and pharmacies when a client consents, and separates medications into rough groups: continue as prescribed, continue at an adjusted dose, taper, or hold pending further assessment.

Antidepressants someone has been taking consistently are usually continued. Stopping them abruptly can produce a discontinuation syndrome that is easily mistaken for withdrawal or returning depression, muddying the picture at the wrong moment. Medications carrying dependence risk get a harder look. Duplicates and prescriptions that were never appropriate get untangled slowly, not all at once.

What almost never happens is the thing people fear most — a blanket confiscation. Treating a psychiatric condition and treating a substance use disorder are not competing projects. The National Institute of Mental Health describes co-occurring substance use and mental illness as common enough that integrated assessment should be routine rather than exceptional, and treating one while ignoring the other tends to leave both unstable. You can read NIMH’s overview of substance use and co-occurring mental disorders for a general summary of that position.

Withdrawal impersonates psychiatric illness

This is the main reason medication decisions get staged rather than made on day one. Someone in the first week off alcohol may present with hand tremor, racing thoughts, dread arriving in waves, and no sleep. Someone in the first weeks off stimulants may be flat, exhausted, unable to feel pleasure, and convinced they have always been this way. Both look like psychiatric illness. Sometimes they are. Sometimes they resolve once the nervous system settles, and a diagnosis made on day two would have committed that person to a medication they did not need.

So the useful question early on is not only what to prescribe but what to observe. Clinicians look for symptoms that predate the substance use, that persisted during previous periods of sobriety, or that clearly exceed what withdrawal would explain. A family member who can say “she was like this at nineteen, before she drank” often contributes more diagnostic information than a rating scale. That is one practical argument for residential treatment over an outpatient schedule: the observation is continuous rather than reconstructed from a fifty-minute appointment two weeks later.

Alcohol and benzodiazepine withdrawal require medical supervision

This point deserves to be stated plainly, without hedging. Withdrawal from alcohol and from benzodiazepines can involve seizures, and in the case of alcohol, delirium tremens — both of which can be life-threatening. These are not withdrawals to manage at home, taper alone, or push through with willpower. Anyone physically dependent on alcohol or a benzodiazepine should be assessed by a medical professional before stopping, and stabilization should happen under supervision with the ability to monitor vital signs and intervene.

Opioid withdrawal is generally less medically dangerous but carries its own serious risk: tolerance drops quickly, and returning to a previously ordinary dose after abstinence can be fatal. That is much of why medication for opioid use disorder is recommended rather than optional in many cases. SAMHSA maintains general guidance on substance use treatment approaches, including medication-assisted options, for readers who want the federal framing. If you are unsure whether someone needs supervised withdrawal, call and ask before making a plan — (855) 778-8668.

The medications that need the most thought

A few categories come up constantly, and none has a single correct answer.

Benzodiazepines prescribed for anxiety in someone with alcohol use disorder are the most common tension. They work, which is the problem — they act on overlapping mechanisms and can maintain the same avoidance pattern the drinking served. Where they are being continued, it is usually as a structured taper rather than an ongoing prescription, and the anxiety is addressed with therapy and non-dependence-forming alternatives in parallel.

Stimulants for attention-deficit/hyperactivity disorder raise a similar question, particularly in someone with a stimulant use history. ADHD is real, it is frequently present alongside substance use disorders, and leaving it untreated has its own costs. The decision usually turns on documentation of the diagnosis, the substance history, and whether non-stimulant options are reasonable first. The National Institute on Drug Abuse discusses the general relationship between substance use disorders and other mental illnesses in its overview of common comorbidities.

Sleep medication is the quiet one. Insomnia in early recovery is close to universal and genuinely awful, but the medications that solve it fastest often carry the most dependence risk. Sleep is usually addressed behaviorally first — consistent wake time, no daytime sleeping, morning light — with medication considered where that is not enough.

Why a six-bed setting changes the work

Annandale Behavioral Health is a small private residence with six beds, not a campus. That matters in an ordinary, practical way: the staff who administer medications are the same staff who see how someone is at breakfast, in the afternoon, and at eleven at night. When a dose change produces agitation, restlessness, or flattening, it is noticed by people who know that person’s baseline.

Medication adjustments are hypotheses, and hypotheses need observation. Our approach to combining that observation with psychiatric care is described further on our dual diagnosis treatment page, and the withdrawal-stabilization side is covered under medical detox.

Questions worth asking before admission

Families are often unsure what they are allowed to ask. Reasonable questions: Is there a psychiatric prescriber on the team, and how often will my family member be seen? Will current prescriptions continue while things are assessed? How are medications stored and administered? Who writes the next refill after discharge?

That last question is the one most often skipped and most often regretted. A carefully built regimen is worthless if it lapses eleven days after discharge because no outpatient prescriber was arranged. A discharge plan should name a prescriber, have an appointment scheduled, and include enough medication to bridge the gap. If you want to talk through what that would look like for a specific situation, you can reach our admissions team at (855) 778-8668.

What a realistic outcome looks like

Nobody leaves residential treatment with a perfect medication regimen, and any program promising one is overselling. What is achievable in a few weeks is a clarified diagnostic picture, an accurate and deduplicated medication list, dependence-forming prescriptions eliminated or on a defined taper, an appropriate medication for opioid or alcohol use disorder where indicated, and a named outpatient prescriber holding the next appointment. Refinement continues for months afterward, and it should.

The man with the grocery bag kept his antidepressant. The duplicate came out, his wife’s prescription went into a disposal container, and the sedative he had taken nightly for four years came down on a schedule across his stay and the months after. He did not leave medication-free, and that was never the goal.

A note on scope

This article is educational and general. It is not medical advice, not a substitute for evaluation by a qualified clinician, and not a basis for starting, stopping, or changing any medication. Do not adjust a prescription on your own, particularly a benzodiazepine, an opioid, or anything you take daily. Speak with your prescriber first.

If you or someone you know is in crisis or thinking about suicide, call or text 988 in the United States to reach the Suicide and Crisis Lifeline, or call 911 for a medical emergency. For help finding treatment, SAMHSA operates a free, confidential national helpline at 1-800-662-4357.